ArticleFrontiers in physiology2025
The microbiological and metabolic traits associated with pT3 colorectal cancer metastasis to lymph nodes.
Article in Frontiers in physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Gut microbiota and metabolites play a crucial role in the progression of colorectal cancer. Over half of the CRC patients are at pT3 stage, the presence or absence of regional lymph node metastasis in pT3 patients significantly influences both treatment strategies and prognosis. However, the associations between these are not been revealed yet. It is crucial to gain a deeper insight into the mechanisms underlying the differences in gut microbiota and metabolites between pT3 CRCs with and without lymph node metastasis. Methods: We processed 16S rRNA gene sequencing and ultrahigh-performance liquid chromatography-mass spectrometry in 70 pT3NxM0 CRC patients. In addition, transcriptomic data from TCGA were retrieved to assess RNA expression differences between the two groups for a comprehensive comparison. Finally, correlation analyses of microbiota, metabolome and transcriptomic data were performed to identify meaningful connections and mechanisms underlying lymph node metastasis. Results: A total of 192 metabolites were different between the patients with and without lymph node metastasis; among these metabolites, 94 upregulated different metabolites were enriched in biological processes of tumor progression. The gut microbiota of lymph node positive CRCs is characterized by increased abundances of cancer progression, such as Conclusion: Our study identified key microbiota and metabolites associated with lymph node metastasis in pT3 colorectal cancer, along with potential pathways and interactions implicated in the lymph node metastasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.